List of Tables
Table 1. Tuberculosis Drugs Market Trends
Table 2. Tuberculosis Drugs Market Drivers & Opportunity
Table 3. Tuberculosis Drugs Market Challenges
Table 4. Tuberculosis Drugs Market Restraints
Table 5. Global Tuberculosis Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Tuberculosis Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Tuberculosis Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Tuberculosis Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Tuberculosis Drugs Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Tuberculosis Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Tuberculosis Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Tuberculosis Drugs
Table 13. Global Tuberculosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Tuberculosis Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Tuberculosis Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Tuberculosis Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Tuberculosis Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Tuberculosis Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Tuberculosis Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Tuberculosis Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Tuberculosis Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Tuberculosis Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Tuberculosis Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Tuberculosis Drugs Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Tuberculosis Drugs Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Tuberculosis Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Tuberculosis Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Tuberculosis Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Tuberculosis Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Tuberculosis Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Tuberculosis Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Tuberculosis Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Tuberculosis Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Tuberculosis Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Tuberculosis Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Tuberculosis Drugs Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Tuberculosis Drugs Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Tuberculosis Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Tuberculosis Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Tuberculosis Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Tuberculosis Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Tuberculosis Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Tuberculosis Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Tuberculosis Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Tuberculosis Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Tuberculosis Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Tuberculosis Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Tuberculosis Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Tuberculosis Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Tuberculosis Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Tuberculosis Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Tuberculosis Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Tuberculosis Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Tuberculosis Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Pfizer Inc Company Information
Table 58. Pfizer Inc Introduction and Business Overview
Table 59. Pfizer Inc Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Pfizer Inc Tuberculosis Drugs Product Offerings
Table 61. Pfizer Inc Recent Development
Table 62. Lupin Laboratories Ltd Company Information
Table 63. Lupin Laboratories Ltd Introduction and Business Overview
Table 64. Lupin Laboratories Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Lupin Laboratories Ltd Tuberculosis Drugs Product Offerings
Table 66. Lupin Laboratories Ltd Recent Development
Table 67. AstraZeneca Plc Company Information
Table 68. AstraZeneca Plc Introduction and Business Overview
Table 69. AstraZeneca Plc Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. AstraZeneca Plc Tuberculosis Drugs Product Offerings
Table 71. AstraZeneca Plc Recent Development
Table 72. Cadila Pharmaceuticals Company Information
Table 73. Cadila Pharmaceuticals Introduction and Business Overview
Table 74. Cadila Pharmaceuticals Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Cadila Pharmaceuticals Tuberculosis Drugs Product Offerings
Table 76. Cadila Pharmaceuticals Recent Development
Table 77. Novartis AG Company Information
Table 78. Novartis AG Introduction and Business Overview
Table 79. Novartis AG Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Novartis AG Tuberculosis Drugs Product Offerings
Table 81. Novartis AG Recent Development
Table 82. Alkem Laboratories Ltd Company Information
Table 83. Alkem Laboratories Ltd Introduction and Business Overview
Table 84. Alkem Laboratories Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Alkem Laboratories Ltd Tuberculosis Drugs Product Offerings
Table 86. Alkem Laboratories Ltd Recent Development
Table 87. Cipla Ltd Company Information
Table 88. Cipla Ltd Introduction and Business Overview
Table 89. Cipla Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Cipla Ltd Tuberculosis Drugs Product Offerings
Table 91. Cipla Ltd Recent Development
Table 92. Otsuka Pharmaceutical Company Information
Table 93. Otsuka Pharmaceutical Introduction and Business Overview
Table 94. Otsuka Pharmaceutical Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Otsuka Pharmaceutical Tuberculosis Drugs Product Offerings
Table 96. Otsuka Pharmaceutical Recent Development
Table 97. Sanofi Company Information
Table 98. Sanofi Introduction and Business Overview
Table 99. Sanofi Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Sanofi Tuberculosis Drugs Product Offerings
Table 101. Sanofi Recent Development
Table 102. Abbott Company Information
Table 103. Abbott Introduction and Business Overview
Table 104. Abbott Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Abbott Tuberculosis Drugs Product Offerings
Table 106. Abbott Recent Development
Table 107. ANI Pharmaceuticals, Inc Company Information
Table 108. ANI Pharmaceuticals, Inc Introduction and Business Overview
Table 109. ANI Pharmaceuticals, Inc Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Offerings
Table 111. ANI Pharmaceuticals, Inc Recent Development
Table 112. Teva Pharmaceutical Industries Ltd Company Information
Table 113. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 114. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Offerings
Table 116. Teva Pharmaceutical Industries Ltd Recent Development
Table 117. Macleods Pharmaceuticals Ltd. Company Information
Table 118. Macleods Pharmaceuticals Ltd. Introduction and Business Overview
Table 119. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Offerings
Table 121. Macleods Pharmaceuticals Ltd. Recent Development
Table 122. Johnson & Johnson Company Information
Table 123. Johnson & Johnson Introduction and Business Overview
Table 124. Johnson & Johnson Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Johnson & Johnson Tuberculosis Drugs Product Offerings
Table 126. Johnson & Johnson Recent Development
Table 127. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Company Information
Table 128. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Introduction and Business Overview
Table 129. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Offerings
Table 131. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Recent Development
Table 132. Eli Lilly and Company Company Information
Table 133. Eli Lilly and Company Introduction and Business Overview
Table 134. Eli Lilly and Company Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Eli Lilly and Company Tuberculosis Drugs Product Offerings
Table 136. Eli Lilly and Company Recent Development
Table 137. Viatris Inc. (Mylan N.V.) Company Information
Table 138. Viatris Inc. (Mylan N.V.) Introduction and Business Overview
Table 139. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Offerings
Table 141. Viatris Inc. (Mylan N.V.) Recent Development
Table 142. Sun Pharmaceutical Industries Ltd. Company Information
Table 143. Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 144. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Offerings
Table 146. Sun Pharmaceutical Industries Ltd. Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Tuberculosis Drugs Downstream Customers
Table 150. Tuberculosis Drugs Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Drugs Product Picture
Figure 2. Global Tuberculosis Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Tuberculosis Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Tuberculosis Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Tuberculosis Drugs Sales Price (2019-2030) & (USD/Unit)
Figure 6. Tuberculosis Drugs Report Years Considered
Figure 7. Global Tuberculosis Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Tuberculosis Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tuberculosis Drugs Revenue in 2023
Figure 10. Tuberculosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. First Line Drugs Therapy Picture
Figure 12. Second Line Drugs Therapy Picture
Figure 13. Combination Drugs Therapy Picture
Figure 14. Global Tuberculosis Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Tuberculosis Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Tuberculosis Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Tuberculosis Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Tuberculosis Drugs Price by Type (2019-2030) & (USD/Unit)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Private Clinic
Figure 21. Product Picture of Others
Figure 22. Global Tuberculosis Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Tuberculosis Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Tuberculosis Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Tuberculosis Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Tuberculosis Drugs Price by Application (2019-2030) & (USD/Unit)
Figure 27. North America Tuberculosis Drugs Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Tuberculosis Drugs Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Tuberculosis Drugs Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Tuberculosis Drugs Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Tuberculosis Drugs Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Tuberculosis Drugs Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Tuberculosis Drugs Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Tuberculosis Drugs Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Tuberculosis Drugs Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Tuberculosis Drugs Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Tuberculosis Drugs Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Tuberculosis Drugs Sales Volume (%), (2019-2030)
Figure 39. United States Tuberculosis Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Tuberculosis Drugs Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Tuberculosis Drugs Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Tuberculosis Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Tuberculosis Drugs Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Tuberculosis Drugs Sales Value by Application (%), 2023 VS 2030
Figure 45. China Tuberculosis Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Tuberculosis Drugs Sales Value by Type (%), 2023 VS 2030
Figure 47. China Tuberculosis Drugs Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Tuberculosis Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Tuberculosis Drugs Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Tuberculosis Drugs Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Tuberculosis Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Tuberculosis Drugs Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Tuberculosis Drugs Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Tuberculosis Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Tuberculosis Drugs Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Tuberculosis Drugs Sales Value by Application (%), 2023 VS 2030
Figure 57. India Tuberculosis Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Tuberculosis Drugs Sales Value by Type (%), 2023 VS 2030
Figure 59. India Tuberculosis Drugs Sales Value by Application (%), 2023 VS 2030
Figure 60. Tuberculosis Drugs Industrial Chain
Figure 61. Tuberculosis Drugs Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
